Evidence map›Paper›PMID 26448181›Full record

ArticlePloS one2015

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.

Marc Rubio, Francesca March, Montserrat Garrigó, Carmen Moreno, Montserrat Español, Pere Coll

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Molecular Mechanisms Underlying Antimicrobial Resistance in Mycobacteria.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Challenges in the Diagnosis and Treatment of Mycobacterium abscessus Infections.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Review
  6. Article
  7. Macrolide resistance inJAC-antimicrobial resistance · 2025
    Review
  8. Article
  9. Exploring antibiotic resistance mechanisms inFrontiers in microbiology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  14. Respirology case reports · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marc RubioDepartament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, Edifici C 08193, Bellaterra (Cerdanyola del Vallès), Spain.
Francesca MarchServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, C/Sant Quintí 89, 08026, Barcelona, Spain.
Montserrat GarrigóServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, C/Sant Quintí 89, 08026, Barcelona, Spain.
Carmen MorenoServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, C/Sant Quintí 89, 08026, Barcelona, Spain.
Montserrat EspañolServei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, C/Sant Quintí 89, 08026, Barcelona, Spain.
Pere CollDepartament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, Edifici C 08193, Bellaterra (Cerdanyola del Vallès), Spain; Servei de Microbiologia, Fundació de Gestió de l'Hospital de la Santa Creu i Sant Pau, C/Sant Quintí 89, 08026, Barcelona, Spain.
Hospital de Sant Pau · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeClarithromycin was considered the cornerstone for the treatment of Mycobacterium abscessus complex infections. Genetic resistance mechanisms have been described and many experts propose amikacin as an alternative. Nevertheless, clarithromycin has several advantages; therefore, it is necessary to identify the non-functional erm(41) allele to determine the most suitable treatment. The aims of this study were to characterize the molecular mechanisms of clarithromycin resistance in a collection of Mycobacterium abscessus complex isolates and to verify the relationship between these mechanisms and the antibiogram. MATERIALS AND

methodsClinical isolates of M. abscessus complex (n = 22) from 16 patients were identified using four housekeeping genes (rpoB, secA1, sodA and hsp65), and their genetic resistance was characterized by studying erm(41) and rrl genes. Nine strains were recovered from the clinical isolates and subjected to E-test and microdilution clarithromycin susceptibility tests, with readings at 3, 7 and 14 days.

resultsWe classified 11/16 (68.8%) M. abscessus subsp. abscessus, 4/16 (25.0%) M. abscessus subsp. bolletii, and 1/16 (6.3%) M. abscessus subsp. massiliense. T28 erm(41) allele was observed in 8 Mycobacterium abscessus subps. abscessus and 3 Mycobacterium abscessus subsp. bolletii. One strain of M. abscessus subsp. bolletii had an erm(41) gene truncated and was susceptible to clarithromycin. No mutations were observed in rrl gene first isolates. In three patients, follow-up of initial rrl wild-type strains showed acquired resistance.

conclusionsMost clinical isolates of M. abscessus complex had inducible resistance to clarithromycin and total absence of constitutive resistance. Our findings showed that the acquisition of resistance mutations in rrl gene was associated with functional and non-functional erm(41) gene. Caution is needed when using erm(41) sequencing alone to identify M. abscessus subspecies. This study reports an acquired mutation at position 2057 of rrl gene, conferring medium-low clarithromycin constitutive resistance.

Indexed as

Anti-Bacterial AgentsClarithromycinDrug Resistance, BacterialGenes, BacterialHumansMicrobial Sensitivity TestsMycobacterium Infections, NontuberculousNontuberculous MycobacteriaAnti-Bacterial AgentsClarithromycin

Identifiers

PMID26448181
PMCPMC4598034
OpenAlexW2254618313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.